Objectives: 1. Describe the factors to consider when transitioning between anticoagulants 2. Identify why transitions to warfarin are significantly different than other anticoagulants View Previous View Next

Objectives: 1. Describe CYP mediated interactions with antibiotics and warfarin 2. Identify the role of cytokines in elevated INR values.

Objectives: 1. Describe the use of cryoprecipitate treating ICH after alteplase. 2. Identify the fibrinogen level associated with ICH risk. View Previous View Next

Objectives: 1. Understand different types of data 2. Recognize common study design flaws View Previous View Next

Objectives: 1. Recognize signs of Upper GI bleeding 2. Differentiate treatment of variceal and non-variceal bleeding View Previous View Next

Objectives: 1. Describe the current controversies in the use of chlorhexidine 2. Describe the current controversies in the use of stress ulcer prophylaxis

Objectives: 1. Recognize the difference between narrowing and stepping down antibiotic therapy 2. Recognize the requirements for clinical improvement after pneumonia treatment

Objectives: 1. Recall the unique properties of ketamine when used for sedation and analgesia 2. Recognize the usual dose for ketamine in various indications View Previous View Next

Objectives: 1. Recall ASPEN position statement on the use of filters with IV lipid emulsion 2. Recognize the additional calories due to lipid emulsions of propofol and clevidipine in critically ill patients View Previous View Next

Objectives: 1. Recognize the importance of de-escalation to patient-centered outcomes 2. Define clinical response to treatment

Objectives: 1. Define deep sedation 2. Recall doses of common medications used for deep sedation View Previous View Next

Objectives: 1. Describe how to assess a patient’s pain 2. Recall mechanisms of pain and different medications to use for each mechanism View Previous View Next